Literature DB >> 58053

Cell interactions in the suppression of in vitro antibody responses.

C E Calkins, S Orbach-Arbouys, O Stutman, R K Gershon.   

Abstract

Normal T and immune B lymphocytes interact in a fashion that leads to suppression of the immune response. Normal spleen cells added to cultures of primed spleen cells specifically suppressed both the IgM and IgG secondary antibody response of the primed cells to less than 30% of the response of the immune cells cultured alone. Cell crowding as a possible in vitro artifact was ruled out. The suppression was specific for the priming antigen, even when the specific and nonspecific antigens were included in the same cultures. Suppression required both normal T and immune B cells to be present in culture. We suggest that the immune population produces a signal that can induce normal T cells to become specific suppressor cells. This form of interaction may represent an important regulatory (homeostatic) mechanism in the immune system.

Mesh:

Substances:

Year:  1976        PMID: 58053      PMCID: PMC2190207          DOI: 10.1084/jem.143.6.1421

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  13 in total

Review 1.  A disquisition on suppressor T cells.

Authors:  R K Gershon
Journal:  Transplant Rev       Date:  1975

Review 2.  Properties of primed suppressor T cells and their products.

Authors:  T Tada; M Taniguchi; T Takemori
Journal:  Transplant Rev       Date:  1975

3.  Regulation of the immune response: production of a soluble suppressor by immune spleen cells in vitro.

Authors:  D W Thomas; W K Roberts; D W Talmage
Journal:  J Immunol       Date:  1975-05       Impact factor: 5.422

4.  Separation of T cell subpopulations capable of DNA synthesis, lymphotoxin release, and regulation of antigen and phytohemagglutinin responses on the basis of density and adherence properties.

Authors:  H G Durkin; J A Bash; B H Waksman
Journal:  Proc Natl Acad Sci U S A       Date:  1975-12       Impact factor: 11.205

5.  A rapid method for the isolation of functional thymus-derived murine lymphocytes.

Authors:  M H Julius; E Simpson; L A Herzenberg
Journal:  Eur J Immunol       Date:  1973-10       Impact factor: 5.532

6.  Suppressor T cells.

Authors:  R K Gershon; P Cohen; R Hencin; S A Liebhaber
Journal:  J Immunol       Date:  1972-03       Impact factor: 5.422

7.  Relationship between antigen and antibody-induced suppression of immunity.

Authors:  E Diener; M Feldmann
Journal:  Transplant Rev       Date:  1972

8.  Feedback induction of suppressor T-cell activity.

Authors:  D D Eardley; R K Gershon
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

9.  Evidence for specific suppression in the maintenance of immunologic tolerance.

Authors:  D C Benjamin
Journal:  J Exp Med       Date:  1975-03-01       Impact factor: 14.307

10.  The thymic suppressor cell. I. Separation of subpopulations with suppressor activity.

Authors:  T Y Ha; B H Waksman; H P Treffers
Journal:  J Exp Med       Date:  1974-01-01       Impact factor: 14.307

View more
  5 in total

1.  Rapid loss of feedback suppressor T-cell activity after priming in vivo.

Authors:  A L Rothermel; C E Calkins
Journal:  Immunology       Date:  1986-04       Impact factor: 7.397

2.  Active role of T cells in promoting an in vitro autoantibody response to self erythrocytes in NZB mice.

Authors:  R D Miller; C E Calkins
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

3.  Suppression of in vitro antibody response by spleen cells of mice infected with Friend-associated lymphatic leukemia virus.

Authors:  M Bendinelli; D Matteucci; A Toniolo; H Friedman
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

4.  Changes in suppressor mechanisms during postnatal development in mice.

Authors:  C E Calkins; O Stutman
Journal:  J Exp Med       Date:  1978-01-01       Impact factor: 14.307

5.  A regulatory role for the memory B cell as suppressor-inducer of feedback control.

Authors:  M W Kennedy; D B Thomas
Journal:  J Exp Med       Date:  1983-02-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.